Celestica Inc. (CLS)
Celestica: Buy Ahead Of Earnings (Preview)
Celestica (CLS) delivered strong Q1 results with 50% YoY revenue growth and 80% YoY adjusted EPS growth. CLS raised FY2026 guidance to $19B revenue (+11.7%) and $10.15 EPS (+16%), with EBIT margin guidance up 300 bps and CAPEX unchanged. Despite robust guidance, CLS shares fell 15.6% post-earnings due to Broadcom's soft AI semiconductor growth and reports of Google seeking alternative suppliers.
Celestica (CLS) Laps the Stock Market: Here's Why
In the most recent trading session, Celestica (CLS) closed at $343.25, indicating a +1.69% shift from the previous trading day.
Celestica (CLS) is an Incredible Growth Stock: 3 Reasons Why
Celestica (CLS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Decoding Celestica: How Custom AI Hardware Is The Most Important Catalyst
Celestica stands to win from Alphabet's $85B capital raise to fund AI capex because it is a key manufacturing partner for Google's tensor processing units (TPUs). Strategic involvement in the Jalapeño project positions Celestica to benefit from multi-year deployments of next-generation custom AI accelerator chips designed by OpenAI and Broadcom through 2029. I expect insourced custom silicon development to be the next major trend. This is a structural tailwind for Celestica via both revenue growth and margin expansion.
Brokers Suggest Investing in Celestica (CLS): Read This Before Placing a Bet
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Celestica (CLS) Declines More Than Market: Some Information for Investors
Celestica (CLS) reached $351.2 at the closing of the latest trading day, reflecting a -6.8% change compared to its last close.
Buy 3 High-Flying AI-Powered EMS Stocks for 2H Amid Solid Demand
AI and cloud infrastructure demand is fueling growth for three EMS leaders, CLS, JBL and SANM, that have surged in 2026 and still have upside ahead.
Can CLS' ATS Segment Sustain Margin Growth Despite Revenue Headwinds?
Celestica's ATS revenues remain roughly flat at $806M, but margin rises to 6% as portfolio shifts and HealthTech strength helped offset key headwinds.
Celestica stock analysis: Will the sell-off continue?
Celestica stock price has slumped in the past few weeks, falling from the all-time high of $655 in June to the current $524. This retreat continued today, even after the company announced a $300 million investment in Texas.
Celestica, Inc. (CLS) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Celestica (CLS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns
The GARP strategy helps investors gain exposure to stocks that have solid prospects and are trading at a discount. TPR, VRT, CLS and COR are some such stocks.
Celestica (CLS) Beats Stock Market Upswing: What Investors Need to Know
Celestica (CLS) reached $403.45 at the closing of the latest trading day, reflecting a +2.63% change compared to its last close.
